{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:27:50Z","timestamp":1793388470081,"version":"4.5.0"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.phrs.2020.105090","type":"journal-article","created":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T12:00:21Z","timestamp":1595332821000},"page":"105090","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":118,"special_numbering":"C","title":["Map kinase signaling as therapeutic target for neurodegeneration"],"prefix":"10.1016","volume":"160","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0322-8169","authenticated-orcid":false,"given":"Touqeer","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abida","family":"Zulfiqar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Arguelles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Rasekhian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Fazel","family":"Nabavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Sanches","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Mohammad","family":"Nabavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2020.105090_bib0005","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1242\/dmm.030205","article-title":"Neurodegenerative disease\u202f: models, mechanisms, and a new hope","volume":"10","author":"Gitler","year":"2017","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.phrs.2020.105090_bib0010","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejmech.2017.09.001","article-title":"European Journal of Medicinal Chemistry Anti-in fl ammatory effects of fl avonoids in neurodegenerative disorders","volume":"153","author":"Spagnuolo","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.phrs.2020.105090_bib0015","doi-asserted-by":"crossref","first-page":"936","DOI":"10.3390\/ijms19040936","article-title":"Disease modeling using 3D organoids derived from human induced pluripotent stem cells","volume":"19","author":"Ho","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2020.105090_bib0020","doi-asserted-by":"crossref","DOI":"10.2174\/1381612824666180327165604","article-title":"Signaling pathways in inflammation and anti-inflammatory therapies","volume":"24","author":"Yeung","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.phrs.2020.105090_bib0025","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1002\/ar.21047","article-title":"MAPK signal transduction underlying brain inflammation and Gliosis as therapeutic target","volume":"1913","author":"Kaminska","year":"2009","journal-title":"Anat. Rec. Adv. Integr. Anat. Evol. Biol."},{"key":"10.1016\/j.phrs.2020.105090_bib0030","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1073\/pnas.0510965103","article-title":"Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses","volume":"14","author":"Chi","year":"2006","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.phrs.2020.105090_bib0035","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a011254","article-title":"MAP kinase pathways","volume":"4","author":"Morrison","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.phrs.2020.105090_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/5380346","article-title":"Clinical trials in alzheimer\u2019s disease: a hurdle in the path of remedy","volume":"2020","author":"Oxford","year":"2020","journal-title":"Int. J. Alzheimers Dis."},{"key":"10.1016\/j.phrs.2020.105090_bib0045","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.00261","article-title":"Pharmacotherapy of alzheimer\u2019s disease: seeking clarity in a time of uncertainty","volume":"11","author":"Husna Ibrahim","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phrs.2020.105090_bib0050","doi-asserted-by":"crossref","DOI":"10.2174\/1874467213666200422090135","article-title":"Recent updates in the Alzheimer\u2019s disease etiopathology and possible treatment approaches: a narrative review of current clinical trials","volume":"13","author":"Zarini-Gakiye","year":"2020","journal-title":"Curr. Mol. Pharmacol."},{"key":"10.1016\/j.phrs.2020.105090_bib0055","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fnins.2019.00043","article-title":"The role of NMDA receptors in alzheimer\u2019s disease","volume":"13","author":"Liu","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.phrs.2020.105090_bib0060","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3389\/fnins.2019.00472","article-title":"Meta-analysis of randomized controlled trials on the efficacy and safety of donepezil, galantamine, Rivastigmine, and memantine for the treatment of alzheimer\u2019s disease","volume":"13","author":"Li","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.phrs.2020.105090_bib0065","doi-asserted-by":"crossref","first-page":"9809","DOI":"10.3390\/ijms15069809","article-title":"Inhibitors of acetylcholinesterase and butyrylcholinesterase meet immunity","volume":"15","author":"Pohanka","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2020.105090_bib0070","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.trci.2015.06.003","article-title":"A 24-week study to evaluate the effect of rilapladib on cognition and cerebrospinal fluid biomarkers of Alzheimer\u2019s disease, Alzheimer\u2019s Dement","volume":"1","author":"Maher-Edwards","year":"2015","journal-title":"Transl. Res. Clin. Interv."},{"key":"10.1016\/j.phrs.2020.105090_bib0075","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/jnc.13750","article-title":"Current and experimental treatments of Parkinson disease: a guide for neuroscientists","volume":"139","author":"Oertel","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.phrs.2020.105090_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/9131474","article-title":"Update on the management of parkinson\u2019s disease for general neurologists","volume":"2020","author":"Pirto\u0161ek","year":"2020","journal-title":"Parkinsons Dis."},{"key":"10.1016\/j.phrs.2020.105090_bib0085","doi-asserted-by":"crossref","first-page":"356","DOI":"10.2174\/1570159X14666151208114634","article-title":"Revisiting the medical management of parkinson\u2019s disease: levodopa versus dopamine agonist","volume":"14","author":"Zhang","year":"2016","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.phrs.2020.105090_bib0090","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1111\/bcp.13651","article-title":"A multiple treatment comparison meta\u2010analysis of monoamine oxidase type B inhibitors for Parkinson\u2019s disease","volume":"84","author":"Binde","year":"2018","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.phrs.2020.105090_bib0095","first-page":"2201","article-title":"Opicapone for the treatment of Parkinson\u2019s disease: an update, Expert Opin","volume":"20","author":"Salamon","year":"2019","journal-title":"Pharmacother."},{"key":"10.1016\/j.phrs.2020.105090_bib0100","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/s41593-018-0236-8","article-title":"Animal models of neurodegenerative diseases","volume":"21","author":"Dawson","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.phrs.2020.105090_bib0105","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.mad.2016.12.008","article-title":"Inflammaging and human longevity in the omics era","volume":"165","author":"Monti","year":"2017","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.phrs.2020.105090_bib0110","doi-asserted-by":"crossref","first-page":"5709","DOI":"10.1523\/JNEUROSCI.0802-06.2006","article-title":"Stress increases vulnerability to inflammation in the rat prefrontal cortex","volume":"26","author":"De Pablos","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2020.105090_bib0115","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.neurobiolaging.2009.01.012","article-title":"Stress is critical for LPS-induced activation of microglia and damage in the rat hippocampus","volume":"32","author":"Espinosa-Oliva","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.phrs.2020.105090_bib0120","first-page":"393769","article-title":"Peripheral inflammation increases the damage in animal models of nigrostriatal dopaminergic neurodegeneration: possible implication in parkinson\u2019s disease incidence","author":"MacHado","year":"2011","journal-title":"Parkinsons Dis."},{"key":"10.1016\/j.phrs.2020.105090_bib0125","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cyto.2008.01.006","article-title":"LPS\/TLR4 signal transduction pathway","volume":"42","author":"Lu","year":"2008","journal-title":"Cytokine."},{"key":"10.1016\/j.phrs.2020.105090_bib0130","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.3390\/ijms20092293","article-title":"Lipopolysaccharide-induced Neuroinflammation as a bridge to understand neurodegeneration","volume":"20","author":"Batista","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2020.105090_bib0135","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3389\/fncel.2017.00216","article-title":"Brain and Peripheral Atypical Inflammatory Mediators Potentiate Neuroinflammation and Neurodegeneration","volume":"11","author":"Kempuraj","year":"2017","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.phrs.2020.105090_bib0140","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/glia.20468","article-title":"Microglia derived from aging mice exhibit an altered inflammatory profile","volume":"55","author":"Sierra","year":"2007","journal-title":"Glia."},{"issue":"2017","key":"10.1016\/j.phrs.2020.105090_bib0145","article-title":"Activation of Ras-ERK signaling and GSK-3 by amyloid precursor protein and amyloid Beta Facilitates neurodegeneration in alzheimer\u2019s disease","volume":"4","author":"Kirouac","year":"2017","journal-title":"ENeuro."},{"key":"10.1016\/j.phrs.2020.105090_bib0150","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.neuint.2018.09.005","article-title":"Activation of \u03b17 nicotinic acetylcholine receptor alleviates A\u03b21-42-induced neurotoxicity via downregulation of p38 and JNK MAPK signaling pathways","volume":"120","author":"Chang","year":"2018","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.phrs.2020.105090_bib0155","article-title":"Signaling in innate immunity and inflammation, cold spring harb","volume":"4","author":"Newton","year":"2012","journal-title":"Perspect. Biol. Med."},{"key":"10.1016\/j.phrs.2020.105090_bib0160","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3389\/fnmol.2015.00077","article-title":"NF-kappaB signaling pathways in neurological inflammation: a mini review","volume":"8","author":"Shih","year":"2015","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.phrs.2020.105090_bib0165","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41392-019-0091-4","article-title":"MKP-1 reduces A\u03b2 generation and alleviates cognitive impairments in Alzheimer\u2019s disease models","volume":"4","author":"Du","year":"2019","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.phrs.2020.105090_bib0170","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.bbamcr.2006.11.011","article-title":"Regulation of gene transcription by mitogen-activated protein kinase signaling pathways","volume":"1773","author":"Whitmarsh","year":"2007","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"},{"key":"10.1016\/j.phrs.2020.105090_bib0175","article-title":"The role of p38 MAPK and its substrates in neuronal plasticity and neurodegenerative disease","volume":"2012","author":"Corr\u00eaa","year":"2012","journal-title":"J. Signal Transduct."},{"key":"10.1016\/j.phrs.2020.105090_bib0180","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1046\/j.1471-4159.2001.00597.x","article-title":"Activation of MKK6, an upstream activator of p38, in Alzheimer\u2019s disease","volume":"79","author":"Zhu","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.phrs.2020.105090_bib0185","doi-asserted-by":"crossref","first-page":"110544","DOI":"10.1016\/j.fct.2019.05.052","article-title":"Targeting pro-senescence mitogen activated protein kinase (Mapk) enzymes with bioactive natural compounds","volume":"131","author":"Cano","year":"2019","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.phrs.2020.105090_bib0190","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0197-4580(03)00126-X","article-title":"Importance of MAPK pathways for microglial pro-inflammatory cytokine IL-1\u03b2 production","volume":"25","author":"Kim","year":"2004","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.phrs.2020.105090_bib0195","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.neuropharm.2009.11.010","article-title":"Targeting p38 MAPK pathway for the treatment of Alzheimer\u2019s disease","volume":"58","author":"Munoz","year":"2010","journal-title":"Neuropharmacology."},{"key":"10.1016\/j.phrs.2020.105090_bib0200","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2174\/187152411794961040","article-title":"p38 MAP kinase inhibitors as potential therapeutic drugs for neural diseases","volume":"11","author":"Yasuda","year":"2012","journal-title":"Cent. Nerv. Syst. Agents Med. Chem."},{"key":"10.1016\/j.phrs.2020.105090_bib0205","first-page":"199","article-title":"The p38 MAP kinase family as regulators of proinflammatory cytokine production in degenerative diseases of the CNS","volume":"1","author":"Bachstetter","year":"2010","journal-title":"Aging Dis."},{"key":"10.1016\/j.phrs.2020.105090_bib0210","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.bbamcr.2007.03.010","article-title":"p38 MAP-Kinases pathway regulation, function and role in human diseases","volume":"1773","author":"Cuenda","year":"2007","journal-title":"Biochim. Biophys. Acta - Mol. Cell Res."},{"key":"10.1016\/j.phrs.2020.105090_bib0215","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.3390\/molecules22081287","article-title":"Recent advances in the inhibition of p38 MAPK as a potential strategy for the treatment of alzheimer\u2019s disease","volume":"22","author":"Lee","year":"2017","journal-title":"Molecules."},{"key":"10.1016\/j.phrs.2020.105090_bib0220","doi-asserted-by":"crossref","first-page":"5606","DOI":"10.4049\/jimmunol.165.10.5606","article-title":"The neuropeptide substance P activates p38 mitogen-activated protein kinase resulting in IL-6 expression independently from NF-\u03baB","volume":"165","author":"Fiebich","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.phrs.2020.105090_bib0225","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.nbd.2016.04.008","article-title":"Protein kinase C\u03b4 upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson\u2019s disease","volume":"93","author":"Gordon","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.phrs.2020.105090_bib0230","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1111\/j.1471-4159.2005.03014.x","article-title":"Inhibition of microglial inflammation by the MLK inhibitor CEP-1347","volume":"92","author":"Lund","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.phrs.2020.105090_bib0235","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jocn.2013.08.017","article-title":"Peripheral expression of MAPK pathways in Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"21","author":"Wang","year":"2014","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.phrs.2020.105090_bib0240","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.4049\/jimmunol.168.8.4070","article-title":"Anti-inflammatory effects of a p38 mitogen-activated protein kinase inhibitor during human endotoxemia","volume":"168","author":"Branger","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.phrs.2020.105090_bib0245","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.expneurol.2014.04.017","article-title":"Intermittent fasting attenuates inflammasome activity in ischemic stroke","volume":"257","author":"Fann","year":"2014","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.phrs.2020.105090_bib0250","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.lfs.2012.06.022","article-title":"Immunosuppressant FK506: Focusing on neuroprotective effects following brain and spinal cord injury","volume":"91","author":"Saganov\u00e1","year":"2012","journal-title":"Life Sci."},{"key":"10.1016\/j.phrs.2020.105090_bib0255","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.celrep.2019.01.019","article-title":"MAP4K4 activation mediates motor neuron degeneration in amyotrophic lateral sclerosis","volume":"26","author":"Wu","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.phrs.2020.105090_bib0260","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/1179069519862798","article-title":"Suppression of MAP4K4 signaling ameliorates motor neuron degeneration in amyotrophic lateral sclerosis-molecular studies toward new therapeutics","volume":"13","author":"Watts","year":"2019","journal-title":"J. Exp. Neurosci."},{"key":"10.1016\/j.phrs.2020.105090_bib0265","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.mam.2011.10.016","article-title":"Neuroinflammation: Modulation by flavonoids and mechanisms of action","volume":"33","author":"Spencer","year":"2012","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.phrs.2020.105090_bib0270","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jalz.2016.02.010","article-title":"Neuroinflammation in Alzheimer\u2019s disease: current evidence and future directions","volume":"12","author":"Calsolaro","year":"2016","journal-title":"Alzheimer\u2019s Dement."},{"key":"10.1016\/j.phrs.2020.105090_bib0275","article-title":"Kainic acid-induced neurodegenerative model: potentials and limitations","volume":"2011","author":"Zheng","year":"2011","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.phrs.2020.105090_bib0280","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1111\/j.1471-4159.2010.06853.x","article-title":"Differences in activation of ERK1\/2 and p38 kinase in Jnk3 null mice following KA treatment","volume":"114","author":"de Lemos","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.phrs.2020.105090_bib0285","first-page":"633","article-title":"JNK3 as a therapeutic target for neurodegenerative diseases., J. Alzheimers","volume":"24","author":"Antoniou","year":"2011","journal-title":"Dis."},{"key":"10.1016\/j.phrs.2020.105090_bib0290","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nn1372","article-title":"Natural oligomers of the amyloid-\u03b2 protein specifically disrupt cognitive function","volume":"8","author":"Cleary","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.phrs.2020.105090_bib0295","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/181260","article-title":"Molecular mechanisms and therapeutic effects of (-)-Epicatechin and other polyphenols in Cancer, inflammation, diabetes, and neurodegeneration","volume":"2015","author":"Shay","year":"2015","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.phrs.2020.105090_bib0300","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.2174\/138161207780858384","article-title":"JNK signalling: a possible target to prevent neurodegeneration","volume":"13","author":"Borsello","year":"2007","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.phrs.2020.105090_bib0305","doi-asserted-by":"crossref","first-page":"10820","DOI":"10.1523\/JNEUROSCI.2824-10.2010","article-title":"Mkp1 is a c-Jun target gene that antagonizes JNK-dependent apoptosis in sympathetic neurons","volume":"30","author":"Kristiansen","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2020.105090_bib0310","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/7043213","article-title":"Flavonoids as therapeutic agents in alzheimer\u2019s and parkinson\u2019s diseases: a systematic review of preclinical evidences","volume":"2018","author":"de Andrade Teles","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.phrs.2020.105090_bib0315","doi-asserted-by":"crossref","DOI":"10.1515\/rns.2011.032","article-title":"c-Jun N-terminal kinases in memory and synaptic plasticity","volume":"22","author":"Sherrin","year":"2011","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.phrs.2020.105090_bib0320","doi-asserted-by":"crossref","first-page":"37332","DOI":"10.1074\/jbc.M113.510412","article-title":"Arrestin-3 binds c-Jun N-terminal kinase 1 (JNK1) and JNK2 and facilitates the activation of these ubiquitous JNK isoforms in cells via scaffolding","volume":"288","author":"Kook","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2020.105090_bib0325","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.neulet.2012.09.048","article-title":"c-Jun N-terminal phosphorylation is essential for hippocampal synaptic plasticity","volume":"531","author":"Seo","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.phrs.2020.105090_bib0330","doi-asserted-by":"crossref","first-page":"336","DOI":"10.2174\/1567202616666181123152601","article-title":"ERK\/MAP kinase activation is evident in activated microglia of the Striatum and substantia nigra in an acute and chronically-induced mouse model of parkinson\u2019s disease","volume":"15","author":"Sarkar","year":"2019","journal-title":"Curr. Neurovasc. Res."},{"key":"10.1016\/j.phrs.2020.105090_bib0335","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.69","article-title":"Induction of COX-2-PGE2 synthesis by activation of the MAPK\/ERK pathway contributes to neuronal death triggered by TDP-43-depleted microglia","volume":"6","author":"Xia","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.phrs.2020.105090_bib0340","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1523\/JNEUROSCI.18-05-01633.1998","article-title":"Extracellular signal-regulated kinase and p38 subgroups of mitogen- activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-\u03b1 gene expression in endotoxin-stimulated primary glial cultures","volume":"18","author":"Bhat","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2020.105090_bib0345","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ceb.2007.02.001","article-title":"The JNK signal transduction pathway","volume":"19","author":"Weston","year":"2007","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.phrs.2020.105090_bib0350","doi-asserted-by":"crossref","first-page":"e6588","DOI":"10.1371\/journal.pone.0006588","article-title":"Phosphorylation of Nrf2 at multiple sites by MAP kinases has a limited contribution in modulating the Nrf2-dependent antioxidant response","volume":"4","author":"Sun","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2020.105090_bib0355","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/458427","article-title":"SOD1 transcriptional and posttranscriptional regulation and its potential implications in ALS","volume":"2011","author":"Milani","year":"2011","journal-title":"Neurol. Res. Int."},{"key":"10.1016\/j.phrs.2020.105090_bib0360","first-page":"321","article-title":"C-jun N-terminal kinase (JNK) signaling as a therapeutic target for alzheimer\u2019s disease","volume":"6","author":"Yarza","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phrs.2020.105090_bib0365","doi-asserted-by":"crossref","first-page":"6245","DOI":"10.1038\/onc.2008.301","article-title":"JNK signaling in apoptosis","volume":"27","author":"Dhanasekaran","year":"2008","journal-title":"Oncogene."},{"key":"10.1016\/j.phrs.2020.105090_bib0370","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s12263-007-0056-z","article-title":"The interactions of flavonoids within neuronal signalling pathways","volume":"2","author":"Spencer","year":"2007","journal-title":"Genes Nutr."},{"key":"10.1016\/j.phrs.2020.105090_bib0375","doi-asserted-by":"crossref","first-page":"682","DOI":"10.18632\/genesandcancer.155","article-title":"JNK-signaling: A multiplexing hub in programmed cell death","volume":"8","author":"Dhanasekaran","year":"2017","journal-title":"Genes Cancer"},{"key":"10.1016\/j.phrs.2020.105090_bib0380","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1016\/j.drudis.2018.08.001","article-title":"Mitochondrial permeability transition pore: a potential drug target for neurodegeneration","volume":"23","author":"Kalani","year":"2018","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.phrs.2020.105090_bib0385","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0165-5728(02)00279-5","article-title":"Inhibition of LPS-induced p42\/44 MAP kinase activation and iNOS\/NO synthesis by parthenolide in rat primary microglial cells","volume":"132","author":"Fiebich","year":"2002","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.phrs.2020.105090_bib0390","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-00225-5","article-title":"Alleviation of microglial activation induced by p38 MAPK\/MK2\/PGE2 axis by capsaicin: potential involvement of other than TRPV1 mechanism\/s","volume":"7","author":"Bhatia","year":"2017","journal-title":"Sci. Rep."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661820313980?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661820313980?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:15:00Z","timestamp":1760912100000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661820313980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":78,"alternative-id":["S1043661820313980"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2020.105090","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Map kinase signaling as therapeutic target for neurodegeneration","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2020.105090","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105090"}}